LPSN - Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LivePerson Inc. (LPSN) | Benzinga

LOS ANGELES, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming January 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LivePerson, Inc. ("LivePerson" or the "Company") (NASDAQ:LPSN) securities between May 10, 2022 and March 16, 2023, inclusive (the "Class Period").

If you suffered a loss on your LivePerson investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/LivePerson-Inc-1/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On February 28, 2023, before market hours, LivePerson disclosed that it would be unable to timely file its Annual Report due to the Company's acquisition of its subsidiary, WildHealth, requiring "more time to perform additional review and testing of revenue recognition with respect to a recently discontinued WildHealth program, for which Medicare reimbursement is suspended pending further governmental review, and to complete its in-process review of internal controls and procedures." On this news, LivePerson's stock price fell $1.69, or 14.3%, to close at $10.12 per share on February 28, 2023, thereby injuring investors.

Then, on March 6, 2023, the Company stated that the "review of WildHealth revenue ...

LPSN)>Full story available on Benzinga.com